In:
British Journal of Pharmacology, Wiley, Vol. 173, No. 6 ( 2016-03), p. 992-1004
Abstract:
Airway microvascular leak (MVL) involves the extravasation of proteins from post‐capillary venules into surrounding tissue. MVL is a cardinal sign of inflammation and an important feature of airway inflammatory diseases such as asthma. PGE 2 , a product of COX‐mediated metabolism of arachidonic acid, binds to four receptors, termed EP 1–4 . PGE 2 has a wide variety of effects within the airway, including modulation of inflammation, sensory nerve activation and airway tone. However, the effect of PGE 2 on airway MVL and the receptor/s that mediate this have not been described. Experimental Approach Evans Blue dye was used as a marker of airway MVL, and selective EP receptor agonists and antagonists were used alongside EP receptor‐deficient mice to define the receptor subtype involved. Key Results PGE 2 induced significant airway MVL in mice and guinea pigs. A significant reduction in PGE 2 ‐induced MVL was demonstrated in Ptger2 − / − and Ptger4 − / − mice and in wild‐type mice pretreated simultaneously with EP 2 (PF‐04418948) and EP 4 (ER‐819762) receptor antagonists. In a model of allergic asthma, an increase in airway levels of PGE 2 was associated with a rise in MVL; this change was absent in Ptger2 − / − and Ptger4 − / − mice. Conclusions and Implications PGE 2 is a key mediator produced by the lung and has widespread effects according to the EP receptor activated. Airway MVL represents a response to injury and under ‘disease’ conditions is a prominent feature of airway inflammation. The data presented highlight a key role for EP 2 and EP 4 receptors in MVL induced by PGE 2.
Type of Medium:
Online Resource
ISSN:
0007-1188
,
1476-5381
Language:
English
Publisher:
Wiley
Publication Date:
2016
detail.hit.zdb_id:
2029728-2
SSG:
15,3
